If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
BERLIN, November Ten (HSMN NewsFeed) — The 500th patient to receive an INCOR® ventricular assist device was implanted on 20 October 2009 at the German Heart Institute Berlin. The 39-year-old male patient was suffering from dilative cardiomyopathy,…
Devices, Cardiology
Berlin Heart, INCOR ventricular assist, left ventricular assist
Posts on ‘November 10th, 2009’
500th Patient Receives an INCOR Ventricular Assist Device at the German Heart Institute Berlin
Stryker Announces Agreements To Acquire Assets
KALAMAZOO, Mich., Nov. 10 (HSMN NewsFeed) — Stryker Corporation (NYSE: SYK ) announced today that it has acquired OtisMed Corporation, a privately held, software technology firm. OtisMed will focus on customizable instrumentation that has the potential …
Devices, Orthopaedic, Acquisitions
Stryker, OtisMed
Neuros Medical Expands Management Team, Forms Advisory Board
CLEVELAND–(HSMN NewsFeed)–Neuros Pharmaceutical, Inc., a clinical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced the expansion of their management team today with the addition of Zi-Ping Fang, PhD, a…
Devices, Neurology, Personnel
Neuros Lab, neurostimulation, neuromodulation
PLC Systems Announces Distribution Agreement for RenalGuard(R) in Brazil
Agreement Signed as a Result of Positive Clinical Trial Results Announced at ESC 2009 and TCT 2009 FRANKLIN, Mass., Nov. 10 (HSMN NewsFeed) — PLC Systems Inc. (OTC Bulletin Board: PLCSF ), a company focused on innovative cardiac and vascular clinical …
Devices, Distribution, Interventional
PLC Systems, DISCOMED, RenalGuard
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab
JERUSALEM–(HSMN NewsFeed)–Teva Pharma Industries Ltd. (Nasdaq: TEVA ) announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company’s Abbreviated New Drug Application (ANDA) to …
Biopharmaceuticals, Generics, Drug Delivery, Litigation
Teva Medical, Takeda Pharmaceuticals, Prevacid, Lansoprazole, SoluTab
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
ALD518 is a Phase II Humanized Monoclonal Antibody Targeting IL-6 PRINCETON, N.J. & BOTHELL, Wash., Nov 10 –(HSMN NewsFeed)– Bristol-Myers Squibb Company (NYSE:BMY ) and Alder Biopharmaceuticals, Inc., today announced a global agreement for the develo…
Biopharmaceuticals
Bristol-Myers Squibb, Alder Biopharmaceuticals, ALD518, rheumatoid arthritis
